ASP Isotopes Inc. Common Stock

NASDAQ:ASPI

Chemicals

Basic Materials
$1.23 +4.79%

+$0.32 today

Market cap
$191.68M
Beta
3.44
P/E (TTM)
-4.9
EPS (TTM)
-$1.43
52W Low $3.92High $14.49

Volume 7.05M

Average 5.68M

ASPI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

ASP Isotopes Inc. Common StockNASDAQ: ASPI

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development grows, but more slowly than its trailing trend

Q1 FY2026 research & development of $5.26M rose 244.0% year over year, behind the +261.3% change in trailing-twelve-month research & development. Sequentially, it fell 23.2% from the prior quarter. Over 3 fiscal years it compounded at +113.3% a year.

Context

  • Research & development amounted to 51.8% of revenue in FY2025, down 23.9 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +244.0% toward the trailing-twelve-month pace of +261.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.26M-23.2% QoQ
Last fiscal yearDec 2025
$12.36M+293.7% YoY
LTMMar 2026
$16.09M+261.3% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+244.0%——
1 year+293.7%——
3-year CAGR+113.3%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
12.36M USD
Year-over-year change
+293.7%
4-year CAGR
+315.1%

Research & Development vs competitors

How ASPI compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +261.3% is the highest of 5, against a peer median of -55.0%.
  • Research & development amounts to 59.8% of revenue for ASPI, versus a peer median of 0.0%.
ASPI Competitors
Research & Development for ASPI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$436M BRL-9.9%+6.4%0.7%
SCLStepan CompanyLTM Mar 2026$59.62M USD+6.3%-3.8%2.5%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$16.09M USD+261.3%+113.3%59.8%
IAUXi-80 Gold Corp.LTM Mar 2026$0 USD——0.0%
ODCOil-Dri Corporation of AmericaLTM Apr 2026$0 USD—+4.5%0.0%
CMPCompass Minerals International, Inc.LTM Mar 2026$0 USD——0.0%
GPREGreen Plains Inc.LTM Mar 2026$0 USD-100.0%—0.0%
WLKPWestlake Chemical Partners LPLTM Mar 2026$0 USD——0.0%
GSMFerroglobe PLCLTM Mar 2026$0 USD——0.0%
UAMYUnited States Antimony CorporationLTM Mar 2026$0 USD——0.0%
TROXTronox Holdings plcLTM Mar 2026$0 USD-100.0%+7.7%0.0%
Peer median (excluding ASPI) —-55.0%+5.4%0.0%

Competitors are the stored peer set for ASPI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00433.03K4.14M23.85M
Cost of Revenue19.38K0294.06K2.55M20.44M
Gross Profit(19.38K)0138.97K1.6M3.41M
Gross Margin——32.1%38.6%14.3%
Research & Development41.61K1.27M764.58K3.14M12.36M
Selling, General & Admin2.55M3.83M15.42M24.81M48.24M
Operating Expenses2.59M5.1M16.18M27.95M60.6M
Depreciation & Amortization19.38K72.57K37.43K471K1.91M
EBITDA(2.59M)(4.87M)(16.14M)(31.58M)(157.07M)
EBITDA Margin——-3728.2%-762.1%-658.6%
Operating Income(2.61M)(5.1M)(16.04M)(26.35M)(57.19M)
Operating Margin——-3704.6%-636.0%-239.8%
Interest Income1153.38K9.07K1.24M6.79M
Interest Expense00118.55K258.87K575K
Other Income / Expenses113153.91K(258.26K)(5.96M)(102.37M)
Income Before Tax(2.61M)(4.95M)(16.3M)(32.31M)(159.56M)
Pre-Tax Margin——-3764.3%-779.7%-669.0%
Income Tax Expense00(6.13K)111.45K282K
Net Income(2.61M)(4.95M)(16.29M)(32.33M)(175.09M)
Net Margin——-3761.0%-780.3%-734.2%
EPS (Basic)(0.08)(0.13)(0.49)(0.63)(2.11)
EPS (Diluted)(0.08)(0.13)(0.49)(0.63)(2.11)
Weighted Avg Shares34.36M35.91M33.07M55.67M83.01M
Weighted Avg Shares (Diluted)34.36M35.91M33.07M55.67M83.01M

ASP Isotopes Inc. Common Stock

NASDAQ:ASPI

Intrinsic Alpha fair value

Locked

Current Price

$1.23

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.